BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 27748980)

  • 1. Tensins are versatile regulators of Rho GTPase signalling and cell adhesion.
    Blangy A
    Biol Cell; 2017 Mar; 109(3):115-126. PubMed ID: 27748980
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tensin 3 is a new partner of Dock5 that controls osteoclast podosome organization and activity.
    Touaitahuata H; Morel A; Urbach S; Mateos-Langerak J; de Rossi S; Blangy A
    J Cell Sci; 2016 Sep; 129(18):3449-61. PubMed ID: 27505886
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The phosphotyrosine-independent interaction of DLC-1 and the SH2 domain of cten regulates focal adhesion localization and growth suppression activity of DLC-1.
    Liao YC; Si L; deVere White RW; Lo SH
    J Cell Biol; 2007 Jan; 176(1):43-9. PubMed ID: 17190795
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dock-family exchange factors in cell migration and disease.
    Gadea G; Blangy A
    Eur J Cell Biol; 2014 Oct; 93(10-12):466-77. PubMed ID: 25022758
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oncogenic inhibition by a deleted in liver cancer gene requires cooperation between tensin binding and Rho-specific GTPase-activating protein activities.
    Qian X; Li G; Asmussen HK; Asnaghi L; Vass WC; Braverman R; Yamada KM; Popescu NC; Papageorge AG; Lowy DR
    Proc Natl Acad Sci U S A; 2007 May; 104(21):9012-7. PubMed ID: 17517630
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The focal adhesion-associated proteins DOCK5 and GIT2 comprise a rheostat in control of epithelial invasion.
    Frank SR; Köllmann CP; van Lidth de Jeude JF; Thiagarajah JR; Engelholm LH; Frödin M; Hansen SH
    Oncogene; 2017 Mar; 36(13):1816-1828. PubMed ID: 27669437
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential regulation of the activity of deleted in liver cancer 1 (DLC1) by tensins controls cell migration and transformation.
    Cao X; Voss C; Zhao B; Kaneko T; Li SS
    Proc Natl Acad Sci U S A; 2012 Jan; 109(5):1455-60. PubMed ID: 22307599
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Full activity of the deleted in liver cancer 1 (DLC1) tumor suppressor depends on an LD-like motif that binds talin and focal adhesion kinase (FAK).
    Li G; Du X; Vass WC; Papageorge AG; Lowy DR; Qian X
    Proc Natl Acad Sci U S A; 2011 Oct; 108(41):17129-34. PubMed ID: 21969587
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The fibronectin-binding integrins alpha5beta1 and alphavbeta3 differentially modulate RhoA-GTP loading, organization of cell matrix adhesions, and fibronectin fibrillogenesis.
    Danen EH; Sonneveld P; Brakebusch C; Fassler R; Sonnenberg A
    J Cell Biol; 2002 Dec; 159(6):1071-86. PubMed ID: 12486108
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ARAP3 is transiently tyrosine phosphorylated in cells attaching to fibronectin and inhibits cell spreading in a RhoGAP-dependent manner.
    I ST; Nie Z; Stewart A; Najdovska M; Hall NE; He H; Randazzo PA; Lock P
    J Cell Sci; 2004 Dec; 117(Pt 25):6071-84. PubMed ID: 15546919
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A phosphorylation switch controls the spatiotemporal activation of Rho GTPases in directional cell migration.
    Cao X; Kaneko T; Li JS; Liu AD; Voss C; Li SS
    Nat Commun; 2015 Jul; 6():7721. PubMed ID: 26166433
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rho GAPs and GEFs: controling switches in endothelial cell adhesion.
    van Buul JD; Geerts D; Huveneers S
    Cell Adh Migr; 2014; 8(2):108-24. PubMed ID: 24622613
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The molecular and clinical role of Tensin 1/2/3 in cancer.
    Mainsiouw L; Ryan ME; Hafizi S; Fleming JC
    J Cell Mol Med; 2023 Jul; 27(13):1763-1774. PubMed ID: 37296531
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DLC1 SAM domain-binding peptides inhibit cancer cell growth and migration by inactivating RhoA.
    Joshi R; Qin L; Cao X; Zhong S; Voss C; Min W; Li SSC
    J Biol Chem; 2020 Jan; 295(2):645-656. PubMed ID: 31806702
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of subcellular targeting sequences of Cten reveals its role in cell proliferation.
    Hong SY; Shih YP; Lo A; Lo SH
    Biochim Biophys Acta Mol Cell Res; 2019 Mar; 1866(3):450-458. PubMed ID: 30321615
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rho regulation: DLC proteins in space and time.
    Braun AC; Olayioye MA
    Cell Signal; 2015 Aug; 27(8):1643-51. PubMed ID: 25889896
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction of deleted in liver cancer 1 with tensin2 in caveolae and implications in tumor suppression.
    Yam JW; Ko FC; Chan CY; Jin DY; Ng IO
    Cancer Res; 2006 Sep; 66(17):8367-72. PubMed ID: 16951145
    [TBL] [Abstract][Full Text] [Related]  

  • 18. P-Rex1 directly activates RhoG to regulate GPCR-driven Rac signalling and actin polarity in neutrophils.
    Damoulakis G; Gambardella L; Rossman KL; Lawson CD; Anderson KE; Fukui Y; Welch HC; Der CJ; Stephens LR; Hawkins PT
    J Cell Sci; 2014 Jun; 127(Pt 11):2589-600. PubMed ID: 24659802
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deleted in liver cancer 1 (DLC1) utilizes a novel binding site for Tensin2 PTB domain interaction and is required for tumor-suppressive function.
    Chan LK; Ko FC; Ng IO; Yam JW
    PLoS One; 2009; 4(5):e5572. PubMed ID: 19440389
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rapid recruitment of p120RasGAP and its associated protein, p190RhoGAP, to the cytoskeleton during integrin mediated cell-substrate interaction.
    Sharma SV
    Oncogene; 1998 Jul; 17(3):271-81. PubMed ID: 9690509
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.